Nature Reviews Endocrinology Эндокринология, диабет и метаболизм
Therapeutic potential of GLP1RAs in diabetic sensorimotor polyneuropathy
Аннотация
Nature Reviews Endocrinology, Published online: 19 November 2026; doi:10.1038/s41574-026-01338-6 The introduction of glucagon-like peptide 1 receptor agonists (GLP1RAs) has transformed the care of patients with type 2 diabetes mellitus. Increasingly, evidence indicates that the benefits of GLP1RAs extend beyond lowering glucose levels; however, limited research has focused on diabetic sensorimotor polyneuropathy.